by Carolyn Thomas ♥ @HeartSisters
As part of our occasional “Dear Carolyn” series of personal patient perspectives shared by my readers, today I’m introducing you to the 13th of our series: two young Florida women, Bethany and Hannah Keime, sisters diagnosed four days apart with a serious cardiac condition called hypertrophic cardiomyopathy (HCM). As described by Mayo Clinic cardiologists, HCM is defined as a heart muscle that becomes thickened, making it harder for the heart to pump blood.
Some people with HCM have few if any warning symptoms, while others may experience palpitations, shortness of breath, fainting or chest pain (especially during exercise) or changes in the heart’s electrical function. Those changes can result in dangerous irregular heart rhythms or sudden death. Because HCM is usually genetic (but not always – Mayo Clinic suggests that “not everyone with HCM has a currently detectable gene mutation”), people with one parent diagnosed with HCM have a 50% chance of having the genetic mutation. Parents, children or siblings of anybody diagnosed with hypertrophic cardiomyopathy should ask their doctor about screening for this disease. Here’s how the Keime sisters individually explained their shared diagnosis: Continue reading “Dear Carolyn: “Two sisters, one ‘heart-charged’ cardiac diagnosis””